pembrolizumabpembrolizumab-chemotherapydoxorubicincarboplatinpaclitaxelcyclophosphamideTriple-negative breast cancer (TNBC)neoadjuvant chemotherapyTNBC
…and poor prognosis. Adding immune checkpoint inhibitors such as pembrolizumab to neoadjuvant chemotherapy has improved pathological response …